Scientists at Oak Ridge National Laboratory and the University of Colorado Boulder used a gene-silencing tool and a large library of molecular guides to understand how photosynthetic bacteria adapt to ...
Pharmaceutical Technology on MSN
AviadoBio broadens vMiX gene silencing licence with King’s College London
The expanded licensing lets AviadoBio pursue partnerships for broader applications, including cardiovascular, nephrology, ...
Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very ...
RNA interference (RNAi) is a fundamental cellular mechanism that regulates gene expression by inducing sequence-specific mRNA degradation. Researchers could utilize the RNAi as a powerful tool to ...
A new possibility for managing cardiovascular disease through RNA interference (RNAi) gene therapies. As cardiovascular diseases continue to be the leading cause of death globally, this technology ...
RNA interference (RNAi) is a conserved post-transcriptional gene regulatory pathway whereby short non-coding RNAs guide silencing complexes to complementary messenger RNAs, resulting in translational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results